Benzer Makaleler
Genetically engineered mice models and generating glioblastoma multiforme in the brain
Yasin Polat, Oytun Erbaş
DOI: 10.5606/fng.btd.2024.147
Sayı: 2024, Cilt 10 - Sayı 1
2908
1963
Balancing Act: NRF2's contradictory roles in cancer progression and therapy
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/fng.btd.2024.160
Sayı: 2024, Cilt 10 - Sayı 3
6373
1248
Microbial influences on cancer: Mechanisms and implications
Gökçen Kılınç, Oytun Erbaş
DOI: 10.5606/fng.btd.2024.161
Sayı: 2024, Cilt 10 - Sayı 3
3182
1092
Expression profiles and regulatory crosstalk of lncRNA HOTAIR and miR-29b-3p across breast cancer subtypes: Implications for tumor progression and therapy resistance
Şara Alagöz, Şehnaz Doğa Kök
DOI: 10.5606/fng.btd.2025.189
Sayı: 2025, Cilt 11 - Sayı 2
907
694
The ZEB1-AS1/ZEB1 axis promotes epithelial-mesenchymal transition in prostate cancer
Gamze Nur Öter, Merve Nur Işık Kolukısaoğlu, İlknur Bingül, Servet Tunoğlu, Canan Küçükgergin
DOI: 10.5606/fng.btd.2025.192
Sayı: 2025, Cilt 11 - Sayı 2
675
589
The role of mesenchymal stem cell exosomes in cancer biology
Alper Demirezen
DOI: 10.5606/fng.btd.2025.186
Sayı: 2025, Cilt 11 - Sayı 2
781
590
Subtype-specific lncRNA signatures: MALAT1 and XIST in breast cancer
Pelin Soytürk, Miray Acer
DOI: 10.5606/fng.btd.2025.206
Sayı: 2025, Cilt 11 - Sayı 3
14
51
Exosomes in cancer progression: Orchestrators of EMT, pre-metastatic niches, and therapy resistance
Irem Yalim Camci, Arzu Aysan, Nursah Ersezen, Iremnur Caglayan
DOI: 10.5606/fng.btd.2025.199
Sayı: 2025, Cilt 11 - Sayı 3
5
33